DAA-based Therapy for Recently Acquired Hepatitis C II (DAA = Directly Acting Antiviral)
Clinical trial NCT02156570 · COMPLETED
Trial details
- NCT number
- NCT02156570
- Sponsor
- Kirby Institute
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2017-08-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.